Pa Patient Saf Advis 2017 Sep;14(3).
Legionella: Could This Potentially Deadly Bacteria Be Lurking in Your Facility’s Water Distribution System?
Gerontology, Infectious Diseases, Internal Medicine and Subspecialties, Nursing
Expand All Collapse All

Terri Lee Roberts, BSN, RN, CIC, FAPIC
Senior Infection Prevention Analyst,
Pennsylvania Patient Safety Authority

Janet E. Stout, PhD
President and Director
Special Pathogens Laboratory

Corresponding Author
Terri Lee Roberts


Legionnaires’ disease is a serious, sometimes lethal pneumonia. The name of this illness originated from an outbreak of severe pneumonia among attendees at an American Legion convention in Philadelphia, Pennsylvania, in 1976. The Pennsylvania Department of Health reports one of the highest annual incidence rates by state. Numerous healthcare facilities have reported outbreaks of healthcare-acquired legionnaires’ disease, with transmission consistently linked to the hot water distribution system. Preventing healthcare-acquired legionnaires’ disease depends upon identifying possible sources where Legionella growth could occur and instituting control measures. Health departments and public agencies have issued infection prevention guidelines to prevent outbreaks. Proactive culturing for Legionella in the hot water distribution system before cases of healthcare-acquired legionnaires' disease are discovered is an evidence-based method of prevention. Superheating and flushing or hyperchlorinating the hot water distribution system are short-term approaches to terminate an outbreak. Long-term systemic water treatment with copper-silver ionization, chlorine dioxide, or monochloramine has also been effective in controlling Legionella.


Legionellosis, a respiratory infection caused by Legionella bacteria, can manifest as legionnaires’ disease or Pontiac fever. Legionnaires’ disease is a serious, sometimes lethal pneumonia accompanied by dry cough, fever, and myalgia. Gastrointestinal tract, central nervous system, and renal manifestations also may be associated. Pontiac fever is a less serious influenza-like, self-limiting illness.1 Risk factors for legionellosis include advanced age, male gender, cigarette smoking, alcohol abuse, chronic pulmonary disease, and renal failure. Immunosuppressed hosts, particularly those receiving corticosteroids or those who have undergone a solid organ transplant, are most frequently involved in healthcare-acquired cases.2 The incubation period for legionnaires’ disease is 2 to 10 days and 1 to 2 days for Pontiac fever. Legionnaires’ disease can be treated successfully with antibiotics in most cases.1 Case fatality ranges from 13% for community-acquired cases up to 33% for healthcare-acquired legionnaires’ disease.2 Millions of healthcare dollars are spent annually treating patients who have legionnaires’ disease.3

Legionellosis is acquired by inhaling aerosols that contain the bacteria or aspirating drinking water that contains the bacteria. Possible sources for water droplets contaminated with Legionella include man-made water distribution systems, such as those in buildings, that provide favorable water temperatures, physical protection within biofilms, and nutrients that promote the growth of Legionella.2 Studies have shown that 20% to 70% of hospital hot water systems have been colonized with Legionella bacteria.4 Numerous healthcare facilities have reported outbreaks of healthcare-acquired legionnaires’ disease with transmission consistently linked to the hot water distribution systems. Decorative water fountains have also been linked to clusters of legionnaires’ disease in healthcare facilities.2

The Centers for Disease Control and Prevention (CDC) investigated the first outbreak of legionnaires’ disease, involving delegates to the American Legion Convention held at a Philadelphia, Pennsylvania, hotel in 1976.5 Legionellosis is a nationally reportable disease, and CDC estimates legionnaires’ disease was diagnosed in 5,000 people in 2014, a four-fold increase since 2000.6 The Pennsylvania Department of Health (PA DOH) reports between 300 and 500 total cases each year, one of the highest annual incidence rates by state.7 The true incidence of legionnaires’ disease is likely higher because of missed diagnosis and underutilization of diagnostic testing.8,9 CDC also reports 20 or more outbreaks of legionnaires’ disease nationally each year, most of which are in buildings with large water systems, such as healthcare facilities.6 CDC’s investigation of legionnaires’ disease outbreaks revealed that healthcare-acquired legionnaires’ disease was responsible for 57% of cases and 85% of deaths from legionnaires' disease.10 The waterborne disease investigative branch of CDC also found Legionella to be responsible for 66% of all waterborne disease outbreaks in the United States between 2011 and 2012.11

Although there are more than 60 species in the Legionella family, Legionella pneumophila causes 80% to 90% of legionnaires’ disease in the United States, with 75% caused by Legionella pneumophila serogroup 1. Only about half of the more than 60 other Legionella species have been implicated in human disease and some species are quite common in the environment but rarely cause infection. Some Legionella organisms are among a group of species that fluoresce blue-white under long-wave ultraviolet light. They are referred to as blue-white fluorescing species and include Legionella anisa, Legionella bozemanii, Legionella dumoffii, and Legionella gormanii. To read more about Legionella species, visit The most commonly used diagnostic test is the Legionella urinary antigen test, which is specific for Legionella pneumophila serogroup 1.8   

Analysts sought to evaluate the incidence of definite and possible healthcare-acquired legionellosis cases and healthcare-acquired legionellosis outbreaks in Pennsylvania from 2007 through 2016.


Analysts used data from Pennsylvania's version of the National Electronic Disease Surveillance System (PA-NEDSS) to review the incidence of legionellosis cases identified and reported in the state. PA-NEDSS receives legionellosis reports from laboratories and healthcare facilities, which is more comprehensive than the Pennsylvania Patient Safety Reporting System or the National Healthcare Safety Network databases that receive legionellosis reports from healthcare facilities only.

PA-NEDSS case definitions are as follows12:

  1. A “case” is defined as healthcare-acquired legionellosis if a patient, employee, visitor, or volunteer spent any amount of time in a healthcare facility (i.e., inpatient or outpatient visits, emergency departments, doctor offices, or long-term care facilities) in the 10 days prior to onset of illness.
    1. A case is defined as “definite” healthcare-acquired legionellosis if the individual spent the entire 10 days in a healthcare facility before symptom onset.
    2. A case is defined as “possible” healthcare-acquired legionellosis if the individual spent a portion of the 10 days in or at a healthcare facility before symptom onset.

A healthcare-acquired legionellosis “outbreak” is defined as the occurrence of two or more cases that are epidemiologically linked (i.e., time, location, and illness characteristics).13


Pennsylvania’s healthcare-acquired legionellosis cases have trended upward over the past 10 years. The numbers of definite healthcare-acquired and possible healthcare-acquired legionellosis cases reported to PA-NEDSS are shown in Figure. The number of healthcare-acquired legionellosis cases doubled from 45 in 2007 to 91 in 2016. Thirteen healthcare-acquired legionellosis outbreaks were reported to PA-NEDSS from 2007 through 2016.


The incidence of healthcare-acquired legionellosis is increasing in Pennsylvania. The reason for the increase is unknown, but many factors play a role. A true increase in the frequency of disease includes human factors of more people at risk due to an aging population and people with weakened immune systems due to underlying illness or immunocompromising medications; and environmental issues of aging plumbing infrastructure and climate change. Increased diagnostic testing and more reliable reporting to PA-NEDSS are also factors.8

The prevention of healthcare-acquired legionnaires’ disease depends on identifying possible sources where Legionella growth could occur and instituting control measures.14 The Allegheny County Health Department in Pittsburgh, Pennsylvania, published the first guideline for preventing healthcare-acquired legionnaires’ disease in the 1990s, based in part on the experience of Pittsburgh investigators at the Veterans Affairs Medical Center. This guideline, “Approaches to Prevention and Control of Legionella Infection in Allegheny County Health Care Facilities,” reviews diagnostic testing for Legionella infection, advocates for proactive environmental surveillance culturing for Legionella in hot water systems, and recommends options for controlling Legionella in water distribution systems.15,16 Routine annual environmental monitoring of water distribution systems—or more often if transplant surgery is performed at the facility—followed by implementation of disinfection methods if indicated, was later shown to significantly reduce healthcare-acquired legionnaires’ disease in Allegheny County and Western Pennsylvania.17 In July 2016, New York passed the first statewide regulation addressing building-associated legionnaires’ disease by mandating proactive culturing of healthcare facility water systems. Hospitals and residential healthcare facilities in New York are required to implement an environmental assessment, develop a Legionella sampling and management plan for their cooling towers and potable water systems, and take necessary responsive actions.18   

The process to develop the first national standard for preventing legionellosis in the United States began in 2005. This process culminated in 2015 with the approval of a new industry standard developed by the American Society for Heating, Refrigerating and Air-conditioning Engineers (ASHRAE). This standard, titled ANSI/ASHRAE Standard 188-2015, Legionellosis: Risk Management for Building Water Systems, is a risk management approach to the control and prevention of building-associated legionnaires’ disease. ASHRAE Standard 188 applies to buildings with any of the following: (1) multiple rooms served by a centralized water heater, (2) 10 or more stories, (3) healthcare facility where patient stays exceed 24 hours, (4) housing immunocompromised individuals, (5) cooling towers, ornamental fountains, and/or whirlpools, and (6) housing occupants older than 65 years. To comply with ASHRAE Standard 188, facility managers need to assess the potential risk in their buildings by performing a survey for devices and building characteristics that have been associated with increased risk for legionnaires’ disease. A program team makes many of the decisions for implementing the standard requirements, including when, where, and how to test for Legionella. This decision-making responsibility can also be a source of liability, including litigation and unfavorable publicity, should the team not seek advice from knowledgeable partners such as water treatment providers and consultants. CDC recognizes this potential gap in knowledge for those implementing ASHRAE Standard 188 and has written “A Practical Guide to Implementing Industry Standards.”4,19

Most recently (in June 2017), the Centers for Medicare and Medicaid Services (CMS) issued a policy memorandum for hospitals and long-term care facilities to raise awareness about facility requirements to prevent Legionella infections. CMS expects Medicare-certified healthcare facilities to develop and adhere to policies and procedures that reduce the risk of growth and spread of Legionella and other opportunistic pathogens in building water systems. CMS surveyors will review policies, procedures, and reports documenting water management implementation results to verify that facilities have taken the following steps:

  1. Conduct a facility risk assessment to identify where Legionella and other opportunistic waterborne pathogens could grow and spread in the facility water system.
  2. Implement a water-management program that considers the ASHRAE industry standard and the CDC toolkit and includes control measures such as physical controls, temperature management, disinfectant level control, visual inspections, and environmental testing for pathogens.
  3. Specify testing protocols and acceptable ranges for control measures, and document the results of testing and corrective actions taken when control limits are not maintained.

CMS expects healthcare facilities to comply with the new requirements to protect the health and safety of its patients. Noncompliance with the requirements will be cited accordingly.20   

Detection of Legionella

When to Test

Environmental testing can be proactive as described above or can follow identification of a case or outbreak. According to CDC, environmental testing should be performed if a single case of definite healthcare-acquired legionnaires’ disease has been diagnosed (the individual spent the entire 10 days in a healthcare facility before symptom onset) or two or more cases of laboratory-confirmed possible healthcare-acquired legionnaires’ disease (the individual spent a portion of the 10 days in or at a healthcare facility before symptom onset) occur within six months of each other.21   

How to Test

Both the ACHD guideline and the New York regulations, for a 500-bed hospital, recommend selecting and testing a minimum of 10 distal sites, faucets or showers, that roughly represent the water distribution system (i.e., sites on multiple floors and wings, and include high-risk units such as hematology and oncology, transplant, medical/surgical, intensive care, and neonatal intensive care).15,18 Note that for sampling potable water systems, testing only hot water systems can be sufficient. The concentration of Legionella recovered from a given outlet has not been shown to correlate with disease risk. Rather, a distal-site positivity rate of 30% or greater for Legionella in a hospital water system has been shown to be a better indicator of risk for healthcare-acquired legionellosis.16,22,23   

Routine surveillance can be performed using either swab or water samples. The results will be affected by the type of sample collected and the method of sample collection. Stout and Yu recommend collecting swab samples before water samples and after removal of the faucet aerator to achieve maximum recovery of Legionella from the biofilm within the fixture. If aerators are not removed, biofilm cannot be adequately sampled and the results can show a false negative. Water samples should be collected from the initial flow of hot water with no flushing of the outlet prior to sample collection. Flushing can reduce the recovery of Legionella. A volume of 250 mL is collected in a sterile bottle. Sample collection supplies are usually provided by the laboratory at no charge. In the context of a case investigation, Stout and Yu recommend that both swab and water samples should be collected from the water outlets in the immediate environment of the suspected case, to optimize sensitivity.24   

For laboratories performing Legionella testing, the standard for environmental microbiology and laboratory quality management is International Organization for Standardization (ISO) 17025. Microbiological culture for Legionella on selective media remains the gold standard for detection per ISO 11731 Water quality -Enumeration of Legionella or ISO 11731-2 Water quality - Detection and enumeration of Legionella.18,25 No other methods, such as direct fluorescent antibody (DFA or dFA) or polymerase chain reaction (PCR), have proven more sensitive or specific for detecting Legionella pneumophila.2

Disinfection of Water Systems   

More than one method can be used to disinfect hot water systems, such as the following: (1) chemical disinfection, such as copper-silver ionization, chlorine dioxide, and monochloramine and (2) physical, such as point-of-use filters placed in high-risk units such as neonatal intensive care or transplant.26

When to Disinfect

Healthcare facilities can consider the following questions to decide whether to install a disinfection system: 

  1. How extensive is the colonization? (Are >30% of outlets positive?)
  2. Is Legionella pneumophila serogroup 1 present?   
  3. Have cases of healthcare-acquired legionnaires’ disease (definite or possible) been diagnosed?   
  4. Is the facility housing at-risk individuals?   

If the answer is yes to one or more of these questions, then consider disinfection. Finding species other than Legionella pneumophila would warrant continuous disinfection if found in a high-risk unit such as bone marrow or solid organ transplant units.16,23,25   

The decision regarding selection of the disinfection method for a healthcare facility is best made by a task force consisting of administrators, infection preventionists, and hospital engineers. Input from the facility’s Infection Prevention and Control Department will help ensure that there will be an evidence-based approach to selection and will include review of relevant literature. Pitfalls exist for choosing a disinfection system based solely upon a vendor’s recommendation. Evaluation of disinfection efficacy can include both Legionella distal site positivity and disinfectant concentrations at select locations. Issues to consider include the necessity for maintenance, regular monitoring, and possible permitting requirements. Objective assessments from other hospitals’ infection preventionists and engineers that have used the systems being evaluated may provide information to help facilities make decisions about what type of disinfection system might be appropriate for their facility.27 Four standard criteria have been recommended to evaluate disinfection methods28:   

  1. Documentation of efficacy in vitro against Legionella
  2. Anecdotal reports of efficacy in controlling Legionella contamination in individual facilities
  3. Peer-reviewed and published reports based on controlled studies of prolonged duration (years) demonstrating the efficacy of controlling Legionella growth and preventing cases of healthcare-acquired legionnaires’ disease in individual facilities
  4. Confirmatory reports from multiple hospitals with prolonged duration of follow-up as validation
How to Disinfect

The most common methods for controlling Legionella in the water distribution system of hospitals and other large buildings are listed in Table. The United States Environmental Protection Agency offers a literature review document of Legionella control measures at: Preference is given to application to the hot water only because this has been shown to be effective in preventing illness, does not add additional chemicals to the drinking water, and requires less chemical addition because the volume of treated hot water is a fraction of the cold water used in a facility.26,27,29

​​​Table. Disinfection Methods for Controlling Legionella in Hospital Water Systems
Disinfection MethodIntermittent or Emergency Short-Term ApplicationsContinuous Applications
Thermal shock treatment (superheat and flush) 
Shock chlorination (>10 mg/L residual, may require water tanks to be at a level of 20 to 50 mg/L) 
Continuous chlorination (2 to 4 mg/L) 
Copper-silver ionization
Chlorine dioxide  
Point-of-use filtration
​Source: Adapted from Lin YE, Stout JE, Yu VL. Controlling Legionella in hospital drinking water: an evidence-based review of disinfection methods. Infect Control Hosp Epidemiol. 2011 Feb;32(2):166-73. PMID: 21460472.
Mg/L, milligrams of chlorine per liter of water.​


The increasing incidence of legionnaires’ disease, the millions of healthcare dollars spent annually in treating these patients, and the high morbidity and mortality associated with legionnaires’ disease provide compelling arguments for a focus on prevention.3,30,31 Evidence-based risk reduction strategies may control and proactively prevent healthcare-acquired legionellosis. Implementation of prevention strategies may save lives and healthcare dollars and control litigation and unfavorable publicity.4 Healthcare facilities are encouraged to renew their focus on prevention in an attempt to reverse the trend of increasing rates of legionnaires’ disease and devastating outbreaks.   


Chandra Marriott, MPH, Pennsylvania Department of Health, Bureau of Epidemiology, contributed to data collection and analysis for this article.

Lauren E. Finn, MPH, Philadelphia Department of Health, Division of Disease Control, Acute Communicable Disease Program, contributed to data collection and analysis for this article.


  1. Committee on Infectious Diseases. Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book. 30th ed. Elk Grove Village (IL): American Academy of Pediatrics; 2015.   
  2. Stout JE, Goetz AM. Legionella pneumophila. In: APIC Text. 4th ed. Arlington (VA): Association for Professionals in Infection Control and Epidemiology (APIC); 2014.   
  3. Collier SA, Stockman LJ, Hicks LA, Garrison LE, Zhou FJ, Beach MJ. Direct healthcare costs of selected diseases primarily or partially transmitted by water. Epidemiol Infect. 2012 Nov;140(11):2003-13. Also available: PMID: 22233584.
  4. Lin YE, Stout JE, Yu VL. Prevention of hospital-acquired legionellosis. Curr Opin Infect Dis. 2011 Aug;24(4):350-6. Also available: PMID: 21666459.
  5. Legionella (Legionnaires' disease and Pontiac fever) - history and disease patterns. [internet]. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2016 May 31 [accessed 2017 Mar 21]. [3 p]. Available:   
  6. Legionnaire's disease. [internet]. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2016 Jun 7 [accessed 2017 Mar 21]. Available:   
  7. Legionellosis fact sheet. [internet]. Harrisburg (PA): Pennsylvania Department of Health; 2016 Apr 18 [accessed 2017 Mar 21]. [4 p]. Available:   
  8. Cooley LA. Legionnaires disease on rise in US - 2016 update. In: Medscape [internet]. New York (NY): WebMD LLC; 2016 Jun 13 [accessed 2017 Mar 21]. [3 p]. Available:   
  9. Hollenbeck B, Dupont I, Mermel LA. How often is a work-up for Legionella pursued in patients with pneumonia? A retrospective study. BMC Infect Dis. 2011 Sep 07;11:237. Also available: PMID: 21899763.
  10. Garrison LE, Kunz JM, Cooley LA, Moore MR, Lucas C, Schrag S, Sarisky J, Whitney CG. Vital signs: deficiencies in environmental control identified in outbreaks of Legionnaires' disease - North America, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016 Jun 10;65(22):576-84. Also available: PMID: 27281485.
  11. Beer KD, Gargano JW, Roberts VA, Hill VR, Garrison LE, Kutty PK, Hilborn ED, Wade TJ, Fullerton KE, Yoder JS. Surveillance for waterborne disease outbreaks associated with drinking water - United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2015 Aug 14;64(31):842-8. Also available: PMID: 26270059.
  12. Marriott C. (Pennsylvania Department of Health, Bureau of Epidemiology). Personal communication re: Pennsylvania Department of Health definitions of definite and possible healthcare-acquired legionellosis cases. 2017 Feb 14.   
  13. Finn LE. (Philadelphia Department of Health, Division of Disease Control, Acute Communicable Disease Program). Personal communication re: Pennsylvania Department of Health definition of healthcare-acquired legionellosis outbreak. 2017 Mar 14.   
  14. Legionellosis fact sheet. [internet]. Geneva (Switzerland): World Health Organization (WHO); 2016 Jun [accessed 2017 Mar 21]. [5 p]. Available:   
  15. 15. Allegheny County Health Department. Approaches to prevention and control of Legionella infection in Allegheny County health care facilities. Pittsburgh (PA): Allegheny County Health Department; 1997 Jan. 15 p. Also available:   
  16. Stout JE, Muder RR, Mietzner S, Wagener MM, Perri MB, DeRoos K, Goodrich D, Arnold W, Williamson T, Ruark O, Treadway C, Eckstein EC, Marshall D, Rafferty ME, Sarro K, Page J, Jenkins R, Oda G, Shimoda KJ, Zervos MJ, Bittner M, Camhi SL, Panwalker AP, Donskey CJ, Nguyen MH, Holodniy M, Yu VL, Legionella Study Group. Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations. Infect Control Hosp Epidemiol. 2007 Jul;28(7):818-24. Also available: PMID: 17564984.
  17. Squier CL, Stout JE, Krsytofiak S, McMahon J, Wagener MM, Dixon B, Yu VL. A proactive approach to prevention of health care-acquired Legionnaires' disease: the Allegheny County (Pittsburgh) experience. Am J Infect Control. 2005 Aug;33(6):360-7. Also available: PMID: 16061143.
  18. N.Y. Comp. Codes R.& Regs. Title 10. Part 4 - Protection Against Legionella § Subpart 4-2 - Health Care Facilities (2016). Also available:   
  19. Developing a water management program to reduce Legionella growth and spread in buildings. A practical guide to implementing industry standards [internet]. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2016 Jun 7 [accessed 2017 Mar 21]. [4 p]. Available:   
  20. Wright DR. (Director, Survey and Certification Group. Centers for Medicare & Medicaid Services, Center for Clinical Standards and Quality/Survey & Certification Group). Memo to State Survey Agency Directors Re: requirement to reduce Legionella risk in healthcare facility water systems to prevent cases and outbreaks of Legionnaires' Disease (LD) [Ref: S&C 17-30 Hospitals/CAHs/NHs Revised 06.09.2017]. 2016 Jun 9. 4 p.   
  21. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, Centers for Disease Control and Prevention (CDC), Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004 Mar 26;53(RR-3):1-36. Also available: PMID: 15048056.
  22. Kool JL, Bergmire-Sweat D, Butler JC, Brown EW, Peabody DJ, Massi DS, Carpenter JC, Pruckler JM, Benson RF, Fields BS. Hospital characteristics associated with colonization of water systems by Legionella and risk of nosocomial Legionnaires' disease: a cohort study of 15 hospitals. Infect Control Hosp Epidemiol. 1999 Dec;20(12):798-805. PMID: 10614602.
  23. Pierre D, Stout JE, Yu VL. Editorial commentary: risk assessment and prediction for health care-associated Legionnaires' disease: percent distal site positivity as a cut-point. Am J Infect Control. 2014 Nov;42(11):1248-50. Also available: PMID: 25444274.
  24. Stout JE, Yu VL. Environmental culturing for Legionella: can we build a better mouse trap? Am J Infect Control. 2010 Jun;38(5):341-3. Also available: PMID: 20569848.
  25. ANSI/ASHRAE Standard 188-2015. Legionellosis: risk management for building water systems. Atlanta (GA): ASHRAE; 2015. Also available:
  26. Baron JL, Peters T, Shafer R, MacMurray B, Stout JE. Field evaluation of a new point-of-use faucet filter for preventing exposure to Legionella and other waterborne pathogens in health care facilities. Am J Infect Control. 2014 Nov;42(11):1193-6. Also available: PMID: 25234046.
  27. Lin YE, Stout JE, Yu VL. Controlling Legionella in hospital drinking water: an evidence-based review of disinfection methods. Infect Control Hosp Epidemiol. 2011 Feb;32(2):166-73. Also available: PMID: 21460472.
  28. Stout JE, Yu VL. Experiences of the first 16 hospitals using copper-silver ionization for Legionella control: implications for the evaluation of other disinfection modalities. Infect Control Hosp Epidemiol. 2003 Aug;24(8):563-8. Also available: PMID: 12940575.
  29. Duda S, Kandiah S, Stout JE, Baron JL, Yassin M, Fabrizio M, Ferrelli J, Hariri R, Wagener MM, Goepfert J, Bond J, Hannigan J, Rogers D. Evaluation of a new monochloramine generation system for controlling Legionella in building hot water systems. Infect Control Hosp Epidemiol. 2014 Nov;35(11):1356-63. Also available: PMID: 25333430.
  30. Benin AL, Benson RF, Besser RE. Trends in Legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis. 2002 Nov 1;35(9):1039-46. Also available: PMID: 12384836.
  31. Neil K, Berkelman R. Increasing incidence of legionellosis in the United States, 1990-2005: changing epidemiologic trends. Clin Infect Dis. 2008 Sep 01;47(5):591-9. Also available: PMID: 18665818.

The Pennsylvania Patient Safety Advisory may be reprinted and distributed without restriction, provided it is printed or distributed in its entirety and without alteration. Individual articles may be reprinted in their entirety and without alteration, provided the source is clearly attributed.

Current and previous issues are available online at

©2019 Pennsylvania Patient Safety Authority